Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Non-fluent Variant Primary Progressive Aphasia
100%
Multimodal Imaging
100%
Progressive Nonfluent Aphasia
100%
Neuroinflammation
70%
Blood Samples
30%
Biological Processes
30%
Blood Biomarkers
30%
2-cycles
20%
11C-ER176
20%
Protein tau
20%
Symptom Severity
20%
Disease Biomarkers
20%
Neuroimaging
20%
Broca's Aphasia
10%
Progressive Mechanism
10%
Clinical Trials
10%
3-Tesla Magnetic Resonance Imaging
10%
Resting-state Functional MRI
10%
Patient Will
10%
Speech-language Assessment
10%
4-repeat tauopathies
10%
Biological Mechanisms
10%
Functional Breakdown
10%
Brain Structure
10%
Functional Magnetic Resonance Imaging
10%
Cognitively Normal
10%
Tau Deposition
10%
Neurodegeneration
10%
Prognostic Marker
10%
Blood Plasma
10%
Biomarker Changes
10%
Structural Abnormalities
10%
Functional Abnormalities
10%
MRI Diffusion
10%
Structural Magnetic Resonance Imaging (sMRI)
10%
Disease Mechanisms
10%
Glial Fibrillary Acidic Protein
10%
Diffusion Tensor Imaging
10%
Clinical Decline
10%
Disease Spread
10%
Diffusion Tensor Tractography
10%
Targeted Treatment
10%
Inflammation Biomarkers
10%
Protein Biomarkers
10%
Brain Changes
10%
Neurodegenerative Disorders
10%
Brain Function
10%
3rd Generation
10%
Magnetic Resonance Imaging Scan
10%
Healthy Controls
10%
Pathological Process
10%
Tau Biomarkers
10%
PET Imaging
10%
Imaging Sequences
10%
Neurofilament Light (NF-L)
10%
Structural Breakdown
10%
Serial Assessment
10%
Apraxia of Speech
10%
Pharmacology, Toxicology and Pharmaceutical Science
Primary Progressive Aphasia
100%
Biological Marker
72%
Nervous System Inflammation
63%
Polyethylene Terephthalate
45%
Diseases
36%
Disease Severity
18%
Carbon 11
18%
Apraxia of Speech
9%
Clinical Trial
9%
Inflammation
9%
Aphasia
9%
Tau Protein
9%
Tauopathy
9%
Glial Fibrillary Acidic Protein
9%
Nerve Degeneration
9%
Neuroscience
Primary Progressive Aphasia
100%
Biological Marker
72%
Blood Plasma
45%
Positron Emission Tomography
36%
Functional Magnetic Resonance Imaging
18%
Tauopathy
9%
Brain Function
9%
Glial Fibrillary Acidic Protein
9%
Positron Emission Tomography
9%
Diffusion MRI
9%
Tau Protein
9%
Neurofilament Light Chain
9%
Tractography
9%
Magnetic Resonance Imaging
9%
Diffusion Tensor Imaging
9%
Brain Structure
9%
Neurodegeneration
9%
Apraxia of Speech
9%
Aphasia
9%
In Vivo
9%
Neurodegenerative Disorder
9%